Paysign's Patient Affordability Drives 51% Revenue Growth and Significant Margin Expansion for First Quarter 2026Business Wire • 05/12/26
Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results; Patient Affordability Drives 40% Revenue Growth and Significant Margin ExpansionBusiness Wire • 03/24/26
Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth ConferenceBusiness Wire • 01/21/26
Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability SolutionsBusiness Wire • 01/07/26
Wall Street Analysts Believe Paysign (PAYS) Could Rally 65.76%: Here's is How to TradeZacks Investment Research • 12/15/25
Does Paysign (PAYS) Have the Potential to Rally 74% as Wall Street Analysts Expect?Zacks Investment Research • 11/28/25
Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor ConferenceBusiness Wire • 11/13/25
Paysign: Gaining Traction In The Patient Affordability Space Into 2026 (Hold)Seeking Alpha • 10/01/25
Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science SolutionsBusiness Wire • 09/22/25
Paysign, Inc. Announces Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative ActionsBusiness Wire • 09/15/25